IMKTA
Ingles Markets, Incorporated
There isn't enough reported data to score IMKTA yet.
IMKTA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
IMKTA's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
IMKTA PE Valuation
IMKTA has no meaningful PE right now: it lost money over the past year.
IMKTA Forward outlook
There aren't enough analyst estimates for IMKTA to show an outlook.
IMKTA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | $2.97 | -65% |
| Q1 2025 | $3.26 | -65% |
| Q4 2024 | $4.14 | -58% |
| Q3 2024 | $5.55 | -50% |
| Q2 2024 | $8.46 | -30% |
| Q1 2024 | $9.33 | -29% |
| Q4 2023 | $9.78 | -33% |
| Q3 2023 | $11.15 | -23% |
IMKTA's earnings per share have fallen from their peak: $2.97 over the past year, against $14.66 in early 2022.
IMKTA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.4B | +1.6% |
| Q1 2026 | $1.3B | -1.8% |
| Q4 2025 | $1.4B | +6.6% |
| Q3 2025 | $1.4B | -2.1% |
| Q2 2025 | $1.3B | -3.4% |
| Q1 2025 | $1.3B | -2.6% |
| Q4 2024 | $1.3B | -13% |
| Q3 2024 | $1.4B | -12% |
IMKTA's revenue grew through 2024 and has held roughly level since: $1.4B last quarter, up 1.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 2.5% | -0.3 points |
| Q1 2026 | 2.6% | +1 points |
| Q4 2025 | 2.9% | +1 points |
| Q3 2025 | 2.6% | +2.7 points |
| Q2 2025 | 2.8% | -0.4 points |
| Q1 2025 | 1.6% | -1.6 points |
| Q4 2024 | 1.8% | -2.2 points |
| Q3 2024 | -0.1% | -4.6 points |
IMKTA's operating margin was 2.5% last quarter, about level with the same quarter a year ago.
IMKTA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $43.6M | -3.9% |
| Q1 2026 | $67.1M | +73% |
| Q4 2025 | $2.1M | +$83.5M |
| Q3 2025 | $36.8M | +577% |
| Q2 2025 | $45.4M | -23% |
| Q1 2025 | $38.9M | +10% |
| Q4 2024 | -$81.4M | -$33.8M |
| Q3 2024 | $5.4M | -90% |
IMKTA still generates free cash flow, though less than at its 2020 peak: $150M over the past year.
IMKTA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.7x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 1.2x | Healthy |
| Q3 2024 | 0.8x | Very low |
IMKTA's net debt is less than a year of its operating earnings (EBITDA).
IMKTA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.2 | Neutral |
| Stochastic | 28.5 | Neutral |
IMKTA's weekly RSI is 47 (neutral) and its Stochastic is 29 (neutral).
IMKTA PE vs Consumer Defensive Sector
| Metric | IMKTA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
IMKTA has no meaningful PE right now: it lost money over the past year.
IMKTA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $85.1 | 1.4% below |
| 20 week MA | $85.9 | 2.4% below |
| 50 week MA | $84.5 | 0.7% below |
| 100 week MA | $75.1 | 12% above |
| 200 week MA | $77.1 | 8.8% above |
IMKTA has slipped below its 8-, 20- and 50-week averages, though it's still 8.8% above its 200-week average.
IMKTA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $47.7 | $40.7 | -15% |
| 2021 | $40.7 | $87.2 | +114% |
| 2022 | $87.2 | $99.2 | +14% |
| 2023 | $99.2 | $86.4 | -13% |
| 2024 | $86.4 | $65.3 | -24% |
| 2025 | $65.3 | $70.3 | +7.6% |
| 2026 YTD | $70.3 | $83.9 | +19% |
IMKTA has finished lower in three of the last six years. It's up 19% so far in 2026.